Familial pulmonary arterial hypertension leucopenia and atrial septal defect
Other Names for this Disease
- Familial pulmonary arterial hypertension, leucopenia and ASD
- Familial PAH, leucopenia and ASD
See Disclaimer regarding information on this site. Some links on this page may take you to organizations outside of the National Institutes of Health.
On this page
The FDA has approved this product to be used in this manner.
|For use of Uptravi (Selexipag) Tablets, 200, 400, 600, 800, 1000, 1200, 1400, and 1600 mcg for treatment of pulmonary arterial hypertension (PAH, WHO Group I) to reduce the risks of disease progression and hospitalization for PAH.|
|More Information about this product||Drug Information Portal|